Multiple Sclerosis Trial, Recruiting NCT06800144 Sponsor: Istanbul Bilgi University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT06800144
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 65 years old.
  • People who have been diagnosed with Multiple Sclerosis (MS) according to a specific set of medical guidelines called the 2017 McDonald criteria.
  • People who have had a pain level of at least 3 out of 10 (on a numbered pain scale) for at least 3 months.
  • People who have not had an MS attack or relapse in the last 3 months.
  • People who have access to a tablet or computer with a working internet connection that can be used for video calls.
  • People who have a smartphone that can connect to a heart rate monitor using Bluetooth.
  • People who are comfortable enough using a smartphone, tablet, or computer to take part in the study, or who have a family member or support person who can help with this.
  • People whose pain medications have not changed in the last 2 months.
  • People who are not receiving any treatments outside of their usual, routine care.
  • People who are able to read and understand Turkish.

Who may not be able to join:

  • People who have a serious condition affecting their muscles, bones, heart, lungs, or metabolism that would prevent them from taking part.
  • People who have another condition apart from MS that could be causing their pain, such as cancer, diabetes, significant joint disease, or rheumatoid arthritis, based on test or scan results.
  • People who have a psychiatric condition (such as active psychosis, severe depression, or anxiety disorders) that would prevent participation, or who have been assessed by a doctor as having a serious cognitive (thinking or memory) problem that would make testing difficult.
  • People who have a serious problem with their vision or hearing.
  • People who are pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 05466017860

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul Bilgi University
Registry
ClinicalTrials.gov
Start date
1 March 2026
Est. completion
1 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Visual Analog Scale (VAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov